The acquisition is expected to strengthen SGS’s agriculture, food, and life business in the United States.
SGS, a Geneva, Switzerland-based analytical contract service provider, announced on May 3, 2019 that it acquired Chemical Solutions (CSL), a Harrisburg, PA-based testing laboratory specializing in elemental and heavy metal testing for pharmaceutical, nutraceuticals, food, and cosmetic products.
CSL provides services to many leading companies in these industries across the United States and internationally. According to SGS, CSL is cGMP registered by FDA, in addition to being International Organization for Standardization (IOS) 17025 accredited. CSL employs approximately 40 employees and made approximately $5.3 million in 2018 revenue.
“This acquisition strengthens our [a]griculture, [f]ood, and [l]ife business in the US, further expanding our scope and geographical presence,” said Frankie Ng, CEO of SGS, in a company press release.
In January 2019, SGS announced a £7.6-million (US$10-million) investment to expand capabilities and capacity for testing cell banks and routine bulk harvest for vaccines, gene and cell therapies, monoclonal antibodies, and other recombinant protein-based biological medicines at the company’s facility in Glasgow, United Kingdom.
Source: SGS
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.